News + Filings Transactions
|
THOMAS PAUL
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/01/2023 | Axogen, Inc. | AXGN | Exercise | Restricted Stock Units | 6.5k | $0.00 | $0 | | 06/01/2023 |
| 08/15/2022 | SURGALIGN HOLDINGS, INC. | RTIX | Grant | Common Stock | 22.9k | $0.00 | $0 | | 08/15/2022 |
| 08/11/2022 | ABIOMED INC | ABMD | Payment of Exercise | Common Stock, $.01 par value | 232 | $293.34 | $68.1k | | 08/10/2022 |
| 08/10/2022 | ABIOMED INC | ABMD | Grant | Common Stock, $.01 par value | 681 | $0.00 | $0 | | 08/10/2022 |
| 06/01/2022 | Axogen, Inc. | AXGN | Grant | Common Stock | 3k | $0.00 | $0 | | 06/01/2022 |
| 06/01/2022 | Axogen, Inc. | AXGN | Exercise | Restricted Stock Units | 3k | $0.00 | $0 | | 06/01/2022 |
| 06/01/2022 | Axogen, Inc. | AXGN | Grant | Stock Option (right to purchase) | 11.8k | $9.29 | $109.7k | | 06/01/2022 |
| 06/01/2022 | Axogen, Inc. | AXGN | Grant | Restricted Stock Units | 6.5k | $0.00 | $0 | | 06/01/2022 |
| 06/01/2021 | Axogen, Inc. | AXGN | Grant | Stock Option (right to buy) | 6k | $19.76 | $119.2k | | 06/01/2021 |
| 06/01/2021 | Axogen, Inc. | AXGN | Grant | Restricted Stock Units | 3k | $0.00 | $0 | | 06/01/2021 |
| 05/07/2021 | SURGALIGN HOLDINGS, INC. | RTIX | Grant | Common Stock | 72.3k | $0.00 | $0 | | 05/07/2021 |
| 05/07/2021 | SURGALIGN HOLDINGS, INC. | RTIX | Grant | Common Stock | 57.8k | $0.00 | $0 | | 05/07/2021 |
| 09/30/2020 | Axogen, Inc. | AXGN | Grant | Stock Option (right to purchase) | 45.9k | $11.63 | $533.9k | | 09/30/2020 |
| 08/12/2020 | ABIOMED INC | ABMD | Grant | Common Stock, $.01 par value | 661 | $0.00 | $0 | | 08/12/2020 |
| 08/10/2020 | ABIOMED INC | ABMD | Sale | Common Stock, $.01 par value | 2k | $303.41 | $606.8k | | 08/07/2020 |
| 08/07/2020 | ABIOMED INC | ABMD | Payment of Exercise | Common Stock, $.01 par value | 390 | $314.98 | $122.8k | | 08/07/2020 |
| 03/02/2020 | ABIOMED INC | ABMD | Sale | Common Stock, $.01 par value | 2k | $151.78 | $303.6k | | 03/02/2020 |
| 02/26/2020 | SURGALIGN HOLDINGS, INC. | RTIX | Grant | Common Stock | 24.7k | $0.00 | $0 | | 02/26/2020 |
| 02/10/2020 | ABIOMED INC | ABMD | Sale | Common Stock, $.01 par value | 2k | $181.13 | $362.3k | | 02/10/2020 |
| 08/08/2019 | ABIOMED INC | ABMD | Payment of Exercise | Common Stock, $.01 par value | 245 | $189.93 | $46.5k | | 08/07/2019 |
| 08/07/2019 | ABIOMED INC | ABMD | Grant | Common Stock, $.01 par value | 1.1k | $0.00 | $0 | | 08/07/2019 |
| 03/08/2019 | RTI SURGICAL, INC. | RTIX | Disposition | Common Stock | 75.7k | $0.00 | $0 | | 03/08/2019 |
| 03/08/2019 | SURGALIGN HOLDINGS, INC. | RTIX | Grant | Common Stock | 75.7k | $0.00 | $0 | | 03/08/2019 |
| 02/26/2019 | RTI SURGICAL, INC. | RTIX | Grant | Common Stock | 21.3k | $0.00 | $0 | | 02/26/2019 |
| 08/08/2018 | ABIOMED INC | ABMD | Grant | Common Stock, $.01 par value | 531 | $0.00 | $0 | | 08/08/2018 |
| 08/08/2018 | ABIOMED INC | ABMD | Payment of Exercise | Common Stock, $.01 par value | 591 | $376.01 | $222.2k | | 08/08/2018 |
| 02/28/2018 | RTI SURGICAL, INC. | RTIX | Grant | Common Stock | 17.6k | $0.00 | $0 | | 02/28/2018 |
| 08/15/2017 | ABIOMED INC | ABMD | Sale | Common Stock, $.01 par value | 10k | $154.71 | $1.5M | | 08/15/2017 |
| 08/13/2017 | ABIOMED INC | ABMD | Payment of Exercise | Common Stock, $.01 par value | 1.3k | $151.37 | $189.8k | | 08/13/2017 |
| 08/09/2017 | ABIOMED INC | ABMD | Grant | Common Stock, $.01 par value | 1.3k | $0.00 | $0 | | 08/09/2017 |
| 08/09/2017 | ABIOMED INC | ABMD | Payment of Exercise | Common Stock, $.01 par value | 787 | $155.87 | $122.7k | | 08/09/2017 |
| 11/10/2016 | Roka BioScience, Inc. | ROKA | Conversion | Common stock, par value $0.001 per share | 7.1k | $7.00 | $50k | | 11/10/2016 |
| 11/10/2016 | Roka BioScience, Inc. | ROKA | Conversion | Series A Convertible Preferred Stock | 50 | $0.00 | $0 | | 11/10/2016 |
| 09/21/2016 | Roka BioScience, Inc. | ROKA | Purchase | Series A Convertible Preferred Stock | 50 | $0.70 | $35 | | 09/21/2016 |
| 09/21/2016 | Roka BioScience, Inc. | ROKA | Purchase | Warrant (right to buy) | 71.4k | $0.70 | $50k | | 09/21/2016 |
|
|